Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-20

Clinical Trial Update: Comparison of Albuterol for Status Asthmaticus [Phase 4]

View source ↗

Summary

Phase 4 trial on albuterol for status asthmaticus was terminated; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albuterol (albuterol)

Snippet

Sponsor: Norton Healthcare | Conditions: Status Asthmaticus | Phase 4 | Status: TERMINATED | Results posted: 2021-05-20